Overview


According to FutureWise analysis the market for Allergic Rhinitis Treatment Device in 2023 is US$ 1.9 billion, and is expected to reach US$ 2.02 billion by 2031 at a CAGR of 3.20%.

Allergic rhinitis, is commonly reffered as hay fever, is a chronic illness characterised by nasal passage irritation caused by an allergic reaction to certain allergens. An individual with allergic rhinitis experiences an overreaction of their immune system, which results in the release of histamine, when they come into touch with allergens such pollen, dust mites, pet dander, or mould spores. The signs of this immunological reaction include sneezing, itching, nasal congestion, runny nose, and itchy or watery eyes. Perennial allergic rhinitis is brought on by allergens that are present all year round, as opposed to seasonal allergic rhinitis, which is brought on by allergens present only at particular seasons of the year. It is a widespread disorder that can have a negative influence on an individual's standard of life, although symptoms can be managed and treated effectively.

The first line of treatment involves allergen avoidance, which includes minimizing exposure to allergens such as pollen, dust mites, or pet dander. Devices that are used to treat allergic rhinitis are referred to as allergic rhinitis therapy devices. It alleviates several symptoms, including runny nose and eyes and helps prevent exposure to various allergens. These technologies for treating allergic rhinitis make use of a wide range of readily available instruments and procedures, such as filters or lasers, to restrict exposure to certain allergens. In addition, the lack of effective medications on the market is also anticipated to contribute to the growth of the global market for devices used to treat allergic rhinitis. 

FutureWise Market Research has published a report that provides an insightful analysis of allergic rhinitis treatment device market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, the allergic rhinitis treatment device market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  •  VIDEOTON Group
  •  Chordate Medical AB
  •  Light Therapy Options, L.L.C.
  •  Hubei YJT Technology Co., Ltd.
  •  Hubei Boshi Medical Instrument Co. Ltd,
  •  Wuhan Opti-Moxibustion International Trading Co., Ltd.
  •  SONOMA PHARMACEUTICALS, INC.
  •  Mylan N.V.
  •  Janssen Pharmaceuticals, Inc.
  •  Teva Pharmaceuticals Company
  •  GSK
  •  Pfizer

(Note: The list of the major players will be updated with the latest market scenario and trends)

The increasing pollution levels have been linked to a rise in the prevalence of allergic rhinitis. Environmental pollutants, such as particulate matter, vehicle emissions, and industrial pollutants, can exacerbate allergic responses and trigger allergic rhinitis symptoms. These pollutants in the air can worsen nasal congestion, sneezing, and other allergic rhinitis symptoms in susceptible individuals. In response to the growing burden of allergic rhinitis, there has been a progressive shift in government support for research and development in the field of allergic rhinitis treatment, which is expected to drive the market. Governments are recognizing the impact of allergic rhinitis on public health and are allocating resources toward research initiatives aimed at better understanding the condition, improving diagnostic tools, and developing more effective treatments. This increased support facilitates advancements in the field and drives the development of innovative solutions for allergic rhinitis management. Moreover, the adoption of innovative tools and the development of new drugs and biomaterials holds promising outcomes for allergic rhinitis patients. These advancements can lead to more targeted and effective treatment approaches. For example, the use of AI and machine learning in the field of rhinology has revolutionized precision in surgeries and medications. These technologies can assist surgeons in planning and performing more accurate and customized interventions, leading to improved patient outcomes. However, there is a shift in the attitude of some patients towards self-medication. With easy access to information and over-the-counter remedies, patients may opt for self-treatment rather than seeking professional advice or investing in specialized devices. This trend can challenge the sales and adoption of allergic rhinitis treatment devices, as patients may not consider them necessary or underestimate their potential benefits.

By Type

  •  Phototherapy
  •  Lasers
  •  Infrared Light
  •  Cryotherapy
  •  Radio waves

By Distribution Channel

  •  Hospitals Pharmacies
  •  Retail Pharmacies
  •  Online Pharmacies

By Region

  •  North America
  •  Europe
  •  Asia-Pacific
  •  Latin America
  • Middle East and Africa

 This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022 due to increased field-specific research & development costs. Sales of devices for treating allergic rhinitis are projected to continue during the evaluation period due to the growing knowledge of the effectiveness of these therapies. A higher wealth per person encourages consumers to use novel therapies for health problems, which drives up market demand for high-quality goods. 

  •  Tier 1 players- established companies in the market with a major market share
  •  Tier 2 players
  •  Emerging players which are growing rapidly
  •  New Entrants
  •  Growth prospects
  •  SWOT analysis
  •  Key trends
  •  Key data-points affecting market growth
  •  To provide with an exhaustive analysis on the Allergic Rhinitis Treatment Device Market By Type, By Distribution Channel and By Region.
  •  To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  •  To evaluate and forecast micro-markets and the overall market
  •  To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  •  To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  •  We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  •  The customization Mobility Care offered are free of charge with purchase of any license of the report
  •  You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Allergic Rhinitis Treatment Device Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Allergic Rhinitis Treatment Device Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Allergic Rhinitis Treatment Device Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Allergic Rhinitis Treatment Device Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Phototherapy
        2. Lasers
        3. Infrared Light
        4. Cryotherapy
        5. Radio waves

  • 8.   Allergic Rhinitis Treatment Device Market, By Distribution Channel Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies

  • 9.   North America Allergic Rhinitis Treatment Device Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Allergic Rhinitis Treatment Device Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Allergic Rhinitis Treatment Device Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Allergic Rhinitis Treatment Device Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. VIDEOTON Group
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Chordate Medical AB
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Light Therapy Options, L.L.C.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Hubei YJT Technology Co., Ltd.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Hubei Boshi Medical Instrument Co. Ltd,
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Wuhan Opti-Moxibustion International Trading Co., Ltd.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. SONOMA PHARMACEUTICALS, INC.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Mylan N.V.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Janssen Pharmaceuticals, Inc.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
         10. Teva Pharmaceuticals Company
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
         11. GSK
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
          12. Pfizer
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 17.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients